Eunice Wang, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY, discusses the mechanisms of resistance to FLT3 inhibitors and some combination strategies which may be able to overcome this when treating patients with acute myeloid leukemia (AML). This interview took place at the 29th Congress of the European Hematology Association (EHA) in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
